CALAS, M.;BARBIER, A.;GIRAL, L.;BALMAYER, B.;DESPAUX, E., EUR. J. MED. CHEM.-CHIM. THER., 1982, 17, N 6, 457-504
作者:CALAS, M.、BARBIER, A.、GIRAL, L.、BALMAYER, B.、DESPAUX, E.
DOI:——
日期:——
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity
作者:Tino Heimburg、Fiona R. Kolbinger、Patrik Zeyen、Ehab Ghazy、Daniel Herp、Karin Schmidtkunz、Jelena Melesina、Tajith Baba Shaik、Frank Erdmann、Matthias Schmidt、Christophe Romier、Dina Robaa、Olaf Witt、Ina Oehme、Manfred Jung、Wolfgang Sippl
DOI:10.1021/acs.jmedchem.7b01447
日期:2017.12.28
Histonedeacetylases (HDACs) are important modulators of epigenetic gene regulation and additionally control the activity of non-histone protein substrates. While for HDACs 1–3 and 6 many potent selective inhibitors have been obtained, for other subtypes much less is known on selective inhibitors and the consequences of their inhibition. The present report describes the development of substituted benzhydroxamic
Reductive monoalkylation of nitro aryls in one-pot
作者:Magne O. Sydnes、Masaki Kuse、Minoru Isobe
DOI:10.1016/j.tet.2008.04.077
日期:2008.6
secondary amines. Further development of the reductive monoalkylation reaction provided conditions that facilitate conversion of a range of different nitro aryls in one-pot to the corresponding secondary benzyl amino aryls in mostly good to excellent yields. This is accomplished by using hydrogen (1 atm) over Pd/C (10%) as reducing agent and benzaldehyde as the benzyl source combined with a stepwise